Jump to content

Cephalotheca foveolata

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Esotericorangepeel (talk | contribs) at 17:46, 6 December 2019 (→‎Physiology). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This template should only be used in the user namespace.This template should only be used in the user namespace.

Cephalotheca foveolata
Scientific classification
Kingdom:
Division:
Class:
Order:
Family:
Genus:
Species:
Cephalotheca foveolata
Binomial name
Cephalotheca foveata
Yaguchi, Nishimura & Udagawa (2006)
  • Cephalotheca faveolata Giridharan, Verekar, Khanna, Mishra, Deshmukh (2012)

Physiology

Cephalotheca foveolata produces a metabolite called sclerotiorin. Sclerotiorin has been shown to induce apoptosis in colon cancer cells by activating a pathway leading to caspase-3 activation. [1]

Lu 2015

  • symptoms of human infection: fevers, upper back pain and shortness of breath (bloodstream infection)[2]
  • found in the soil and on other environmental matter[2]
  • teleomorph (sexual) and anamorph (asexual) stages in vitro and in natural habitat. The anamorph morphology akin to Phialemonium and Acremonium[2]
  • 7 case as of 2011 ( in eyes, lymph nodes, cardiac tissue and bronchial lavage fluid)[2]
  • 1st reported case of bloodstream infection in 2011[2]
  • potentially an opportunistic human pathogen[2]
  • produce a brown to reddish diffusing pigment (on PFA)[2]
  • amphotericin B, itraconazole, posaconazole and voriconazole inhibit all growth at lowest concentration after 48 hours at 35°C[2]
  • Caspofungin causes abnormal growth at the lowest concentration after 24 hours[2]
  • potentially found on human skin or in foods as a contaminant[2]
  • since morphology is similar to other pathogenic species DNA analysis of the 28S rDNA is required for identification[2]
  • environmental niche currently unknown[2]

Pedromo 2011

  • molecularly and morphologically related to P. obovatum[3]
  • reported in Singapore, Texas, South Carolina, Ohio, North Carolina[3]
  • reported in Endocarditis, lymph node, bronchial fluid, eyes[3]
  • resistant to AMB[3]

Suh 2005

  • first case of sub cutaneous Cephalotheca foveolata in 2006 (erythematous plaques with clear boundary)[4]
  • surgical removal worked (followed for a year afterwards)[4]
  • Saprophytic, found in soil, wood and mushrooms.[4]
  • full blood count, peripheral blood smear, urinalysis, liver and renal function tests, and stool examination were within normal limits (aka, subcutaneous infection won’t impact those organs)[4]
  • chronic granulomatous inflammation around infection[4]
  • ellipsoidal conidia at the end of short conidiophores [4]
  • itraconazole for the first 3 months and then with terbinafine for another 9 months led to no change[4]
  • D1/D2 variable domains of 28S rDNA must be analysed to differentiate from similar pathogenic species[4]

Sutton 2008

  • one of few Ascomycetes that is homothallic and makes teleomorph structures in vitro[5]
  • Cephalotheca foveolate is rare[5]

Yaguchi 2006

  • first isolated/defined in 2006 (in Korea), subcutaneous infection of foot[6]
  • Phialemonium-like conidia (also similar to the hyphomycete Teberdinia)[6]
  • ascomycota have yellow straight or wavy hairs[6]
  • pitted, kidney shaped ascospores (4-5x3-4x2.5-3µm), translucent/yellowish[6]
  • 95% homology to Cephalotheca sulfurea[6]
  • max growth temp 39°C[6]
  • 25°C growth faster than 35°C growth[6]
  • colonies reach 45-50mm diameter in vitro (OA media or PDA media) in 14 days at 25°C[6]
  • conidiogenesis does occur in vitro[6]
  • in vitro: black, brown, white, orange even yellowish sometimes[6]
  • Cleistothecia fruiting bodies[6]
  • peridium is made of elongated, thick walled cells[6]
  • translucent/brownish, 8 celled asci[6]
  • conidiogenous cells undifferentiated from hyphae but at the terminal end (monophhialidic), cylindrical, 10-20x2-3µm[6]
  • Conidia are translucent, cylindrical, and 4-5x1.5-2µm[6]
  • 3-6µm thick walled chlamydospores[6]

Tsang 2017

  • Cephalotheca foveolata is appearing in Hong Kong recently[7]

References

  1. ^ Giridharan P, Verekar SA, Khanna A, Mishra PD, Deshmukh SK (2012). "Anticancer activity of sclerotiorin, isolated from an endophytic fungus Cephalotheca faveolata Yaguchi, Nishim. & Udagawa". Indian Journal of Experimental Biology. 50 (7): 464–468. PMID 22822525.
  2. ^ a b c d e f g h i j k l Lu L, Weil A, Wiederhold N, Sutton D, Chesnut L, Lindner J, Fan H, Tingpej B, El-Khoury J, Kwon D (2015). "Probable case of Cephalotheca foveolata bloodstream infection". JMM case reports. 2 (4): 1–5. doi:10.1099/jmmcr.0.000045.
  3. ^ a b c d Perdomo H, Sutton D, García D, Fothergill A, Gene J, Cano J, Summerbell R, Rinaldi M, Guarro J (2011). "Molecular and Phenotypic Characterization of Phialemonium and Lecythophora Isolates from Clinical Samples". Journal of Clinical Microbiology. 49 (4): 1209–1216. doi:10.1128/JCM.01979-10.
  4. ^ a b c d e f g h Suh M, Lim J, Lee Y, Ha G, Kim H, Kim J, Yaguchi T, Nishimura K (2005). "Subcutaneous hyalohyphomycosis due to Cephalotheca foveolata in an immunocompetent host". British Journal of Dermatology. 154 (6): 1184–1189. doi:10.1111/j.1365-2133.2006.07158.x.
  5. ^ a b Sutton D, MT, SM(ASCP), RM, SM(NRM) (2008). "Rare and Emerging Agents of Hyalohyphomycosis". Current Fungal Infection Reports. 2 (3): 134–142. doi:10.1007/s12281-008-0020-4.
  6. ^ a b c d e f g h i j k l m n o p Yaguchi T, Sano A, Yarita K, Suh M, Nishimura K, Udagawa S (2006). "A new species of Cephalotheca isolated from a Korean patient". Mycotaxon. 96: 30–322. {{cite journal}}: Cite has empty unknown parameter: |1= (help)CS1 maint: extra punctuation (link)
  7. ^ Tsang C (2017). "Diversity of novel and emerging pathogenic fungi in Hong Kong". The University of Hong Kong. {{cite journal}}: Cite has empty unknown parameter: |1= (help)CS1 maint: extra punctuation (link)